Oryzon Genomics Sa (0RDB)
LSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 49.74M | 61.04M | 67.45M | 80.09M | 94.11M | 95.38M | 103.7M | 106.9M |
| Total Current Assets | 28.48M | 36.13M | 35.66M | 37.74M | 42.38M | 32.61M | 25.17M | 14.28M |
| Cash and Equivalents | 22.03M | 34.95M | 34.32M | 35.11M | 39.61M | 28.73M | 21.32M | 12.26M |
| Total Non-Current Assets | 22.73M | 34.43M | 45.13M | 61.13M | 75.93M | 71.26M | 72.57M | 81.78M |
| Total Liabilities | 27.02M | 26.61M | 22.33M | 18.97M | 18.18M | 24.12M | 31.13M | 25.13M |
| Total Current Liabilities | 7.6M | 8.7M | 10.44M | 10.55M | 7.69M | 8.67M | 18.73M | 16.42M |
| Total Non-Current Liabilities | 34.35M | 31.02M | 19.28M | 12.2M | 15.79M | 25.8M | 19.46M | 12.16M |
| Total Equity | 22.73M | 34.43M | 45.13M | 61.13M | 75.93M | 71.26M | 72.57M | 81.78M |
| Common Equity | 1.42M | 1.71M | 1.96M | 2.29M | 2.65M | 2.65M | 2.78M | 3.06M |
| Retained Earnings | -9.54M | -14.74M | -15.92M | -19.5M | -3.4M | -8.09M | -12.32M | -15.67M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
